A carregar...
Ribavirin revisited in the era of direct‐acting antiviral therapy for hepatitis C virus infection
Over the past two decades, ribavirin has been an integral component of treatment for hepatitis C virus (HCV) infection, where it has been shown to improve the efficacy of (pegylated) interferon. However, because of treatment‐limiting side effects and its additive toxicity with interferon, the search...
Na minha lista:
| Publicado no: | Liver Int |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5216450/ https://ncbi.nlm.nih.gov/pubmed/27473533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.13212 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|